Global Rivaroxaban Market Growth 2022-2028
As the global economy mends, the 2021 growth of Rivaroxaban will have significant change from previous year. According to our latest study, the global Rivaroxaban market size is USD million in 2022 from USD 7821.1 million in 2021, with a change of % between 2021 and 2022. The global Rivaroxaban market size will reach USD 13850 million in 2028, growing at a CAGR of 8.5% over the analysis period.
The United States Rivaroxaban market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rivaroxaban market, reaching US$ million by the year 2028. As for the Europe Rivaroxaban landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Rivaroxaban players cover Bayer, J&J, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Rivaroxaban market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
2.5 mg
10 mg
15 mg
20 mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Acute Coronary Syndrome (ACS)
Venous Thromboembolism (VTE)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bayer
J&J
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rivaroxaban Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Rivaroxaban by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Rivaroxaban by Country/Region, 2017, 2022 & 2028
2.2 Rivaroxaban Segment by Type
2.2.1 2.5 mg
2.2.2 10 mg
2.2.3 15 mg
2.2.4 20 mg
2.3 Rivaroxaban Sales by Type
2.3.1 Global Rivaroxaban Sales Market Share by Type (2017-2022)
2.3.2 Global Rivaroxaban Revenue and Market Share by Type (2017-2022)
2.3.3 Global Rivaroxaban Sale Price by Type (2017-2022)
2.4 Rivaroxaban Segment by Application
2.4.1 Acute Coronary Syndrome (ACS)
2.4.2 Venous Thromboembolism (VTE)
2.5 Rivaroxaban Sales by Application
2.5.1 Global Rivaroxaban Sale Market Share by Application (2017-2022)
2.5.2 Global Rivaroxaban Revenue and Market Share by Application (2017-2022)
2.5.3 Global Rivaroxaban Sale Price by Application (2017-2022)
3 Global Rivaroxaban by Company
3.1 Global Rivaroxaban Breakdown Data by Company
3.1.1 Global Rivaroxaban Annual Sales by Company (2020-2022)
3.1.2 Global Rivaroxaban Sales Market Share by Company (2020-2022)
3.2 Global Rivaroxaban Annual Revenue by Company (2020-2022)
3.2.1 Global Rivaroxaban Revenue by Company (2020-2022)
3.2.2 Global Rivaroxaban Revenue Market Share by Company (2020-2022)
3.3 Global Rivaroxaban Sale Price by Company
3.4 Key Manufacturers Rivaroxaban Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rivaroxaban Product Location Distribution
3.4.2 Players Rivaroxaban Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rivaroxaban by Geographic Region
4.1 World Historic Rivaroxaban Market Size by Geographic Region (2017-2022)
4.1.1 Global Rivaroxaban Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Rivaroxaban Annual Revenue by Geographic Region
4.2 World Historic Rivaroxaban Market Size by Country/Region (2017-2022)
4.2.1 Global Rivaroxaban Annual Sales by Country/Region (2017-2022)
4.2.2 Global Rivaroxaban Annual Revenue by Country/Region
4.3 Americas Rivaroxaban Sales Growth
4.4 APAC Rivaroxaban Sales Growth
4.5 Europe Rivaroxaban Sales Growth
4.6 Middle East & Africa Rivaroxaban Sales Growth
5 Americas
5.1 Americas Rivaroxaban Sales by Country
5.1.1 Americas Rivaroxaban Sales by Country (2017-2022)
5.1.2 Americas Rivaroxaban Revenue by Country (2017-2022)
5.2 Americas Rivaroxaban Sales by Type
5.3 Americas Rivaroxaban Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rivaroxaban Sales by Region
6.1.1 APAC Rivaroxaban Sales by Region (2017-2022)
6.1.2 APAC Rivaroxaban Revenue by Region (2017-2022)
6.2 APAC Rivaroxaban Sales by Type
6.3 APAC Rivaroxaban Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rivaroxaban by Country
7.1.1 Europe Rivaroxaban Sales by Country (2017-2022)
7.1.2 Europe Rivaroxaban Revenue by Country (2017-2022)
7.2 Europe Rivaroxaban Sales by Type
7.3 Europe Rivaroxaban Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rivaroxaban by Country
8.1.1 Middle East & Africa Rivaroxaban Sales by Country (2017-2022)
8.1.2 Middle East & Africa Rivaroxaban Revenue by Country (2017-2022)
8.2 Middle East & Africa Rivaroxaban Sales by Type
8.3 Middle East & Africa Rivaroxaban Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rivaroxaban
10.3 Manufacturing Process Analysis of Rivaroxaban
10.4 Industry Chain Structure of Rivaroxaban
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rivaroxaban Distributors
11.3 Rivaroxaban Customer
12 World Forecast Review for Rivaroxaban by Geographic Region
12.1 Global Rivaroxaban Market Size Forecast by Region
12.1.1 Global Rivaroxaban Forecast by Region (2023-2028)
12.1.2 Global Rivaroxaban Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rivaroxaban Forecast by Type
12.7 Global Rivaroxaban Forecast by Application
13 Key Players Analysis
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Rivaroxaban Product Offered
13.1.3 Bayer Rivaroxaban Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Rivaroxaban Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Rivaroxaban Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 2.5 mg
Table 4. Major Players of 10 mg
Table 5. Major Players of 15 mg
Table 6. Major Players of 20 mg
Table 7. Global Rivaroxaban Sales by Type (2017-2022) & (M Units)
Table 8. Global Rivaroxaban Sales Market Share by Type (2017-2022)
Table 9. Global Rivaroxaban Revenue by Type (2017-2022) & ($ million)
Table 10. Global Rivaroxaban Revenue Market Share by Type (2017-2022)
Table 11. Global Rivaroxaban Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Rivaroxaban Sales by Application (2017-2022) & (M Units)
Table 13. Global Rivaroxaban Sales Market Share by Application (2017-2022)
Table 14. Global Rivaroxaban Revenue by Application (2017-2022)
Table 15. Global Rivaroxaban Revenue Market Share by Application (2017-2022)
Table 16. Global Rivaroxaban Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Rivaroxaban Sales by Company (2020-2022) & (M Units)
Table 18. Global Rivaroxaban Sales Market Share by Company (2020-2022)
Table 19. Global Rivaroxaban Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Rivaroxaban Revenue Market Share by Company (2020-2022)
Table 21. Global Rivaroxaban Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Rivaroxaban Producing Area Distribution and Sales Area
Table 23. Players Rivaroxaban Products Offered
Table 24. Rivaroxaban Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Rivaroxaban Sales by Geographic Region (2017-2022) & (M Units)
Table 28. Global Rivaroxaban Sales Market Share Geographic Region (2017-2022)
Table 29. Global Rivaroxaban Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Rivaroxaban Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Rivaroxaban Sales by Country/Region (2017-2022) & (M Units)
Table 32. Global Rivaroxaban Sales Market Share by Country/Region (2017-2022)
Table 33. Global Rivaroxaban Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Rivaroxaban Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Rivaroxaban Sales by Country (2017-2022) & (M Units)
Table 36. Americas Rivaroxaban Sales Market Share by Country (2017-2022)
Table 37. Americas Rivaroxaban Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Rivaroxaban Revenue Market Share by Country (2017-2022)
Table 39. Americas Rivaroxaban Sales by Type (2017-2022) & (M Units)
Table 40. Americas Rivaroxaban Sales Market Share by Type (2017-2022)
Table 41. Americas Rivaroxaban Sales by Application (2017-2022) & (M Units)
Table 42. Americas Rivaroxaban Sales Market Share by Application (2017-2022)
Table 43. APAC Rivaroxaban Sales by Region (2017-2022) & (M Units)
Table 44. APAC Rivaroxaban Sales Market Share by Region (2017-2022)
Table 45. APAC Rivaroxaban Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Rivaroxaban Revenue Market Share by Region (2017-2022)
Table 47. APAC Rivaroxaban Sales by Type (2017-2022) & (M Units)
Table 48. APAC Rivaroxaban Sales Market Share by Type (2017-2022)
Table 49. APAC Rivaroxaban Sales by Application (2017-2022) & (M Units)
Table 50. APAC Rivaroxaban Sales Market Share by Application (2017-2022)
Table 51. Europe Rivaroxaban Sales by Country (2017-2022) & (M Units)
Table 52. Europe Rivaroxaban Sales Market Share by Country (2017-2022)
Table 53. Europe Rivaroxaban Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Rivaroxaban Revenue Market Share by Country (2017-2022)
Table 55. Europe Rivaroxaban Sales by Type (2017-2022) & (M Units)
Table 56. Europe Rivaroxaban Sales Market Share by Type (2017-2022)
Table 57. Europe Rivaroxaban Sales by Application (2017-2022) & (M Units)
Table 58. Europe Rivaroxaban Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Rivaroxaban Sales by Country (2017-2022) & (M Units)
Table 60. Middle East & Africa Rivaroxaban Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Rivaroxaban Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Rivaroxaban Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Rivaroxaban Sales by Type (2017-2022) & (M Units)
Table 64. Middle East & Africa Rivaroxaban Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Rivaroxaban Sales by Application (2017-2022) & (M Units)
Table 66. Middle East & Africa Rivaroxaban Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Rivaroxaban
Table 68. Key Market Challenges & Risks of Rivaroxaban
Table 69. Key Industry Trends of Rivaroxaban
Table 70. Rivaroxaban Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Rivaroxaban Distributors List
Table 73. Rivaroxaban Customer List
Table 74. Global Rivaroxaban Sales Forecast by Region (2023-2028) & (M Units)
Table 75. Global Rivaroxaban Sales Market Forecast by Region
Table 76. Global Rivaroxaban Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Rivaroxaban Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Rivaroxaban Sales Forecast by Country (2023-2028) & (M Units)
Table 79. Americas Rivaroxaban Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Rivaroxaban Sales Forecast by Region (2023-2028) & (M Units)
Table 81. APAC Rivaroxaban Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Rivaroxaban Sales Forecast by Country (2023-2028) & (M Units)
Table 83. Europe Rivaroxaban Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Rivaroxaban Sales Forecast by Country (2023-2028) & (M Units)
Table 85. Middle East & Africa Rivaroxaban Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Rivaroxaban Sales Forecast by Type (2023-2028) & (M Units)
Table 87. Global Rivaroxaban Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Rivaroxaban Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Rivaroxaban Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Rivaroxaban Sales Forecast by Application (2023-2028) & (M Units)
Table 91. Global Rivaroxaban Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Rivaroxaban Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Rivaroxaban Revenue Market Share Forecast by Application (2023-2028)
Table 94. Bayer Basic Information, Rivaroxaban Manufacturing Base, Sales Area and Its Competitors
Table 95. Bayer Rivaroxaban Product Offered
Table 96. Bayer Rivaroxaban Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Bayer Main Business
Table 98. Bayer Latest Developments
Table 99. J&J Basic Information, Rivaroxaban Manufacturing Base, Sales Area and Its Competitors
Table 100. J&J Rivaroxaban Product Offered
Table 101. J&J Rivaroxaban Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. J&J Main Business
Table 103. J&J Latest Developments
List of Figures
Figure 1. Picture of Rivaroxaban
Figure 2. Rivaroxaban Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rivaroxaban Sales Growth Rate 2017-2028 (M Units)
Figure 7. Global Rivaroxaban Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Rivaroxaban Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 2.5 mg
Figure 10. Product Picture of 10 mg
Figure 11. Product Picture of 15 mg
Figure 12. Product Picture of 20 mg
Figure 13. Global Rivaroxaban Sales Market Share by Type in 2021
Figure 14. Global Rivaroxaban Revenue Market Share by Type (2017-2022)
Figure 15. Rivaroxaban Consumed in Acute Coronary Syndrome (ACS)
Figure 16. Global Rivaroxaban Market: Acute Coronary Syndrome (ACS) (2017-2022) & (M Units)
Figure 17. Rivaroxaban Consumed in Venous Thromboembolism (VTE)
Figure 18. Global Rivaroxaban Market: Venous Thromboembolism (VTE) (2017-2022) & (M Units)
Figure 19. Global Rivaroxaban Sales Market Share by Application (2017-2022)
Figure 20. Global Rivaroxaban Revenue Market Share by Application in 2021
Figure 21. Rivaroxaban Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Rivaroxaban Revenue Market Share by Company in 2021
Figure 23. Global Rivaroxaban Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Rivaroxaban Revenue Market Share by Geographic Region in 2021
Figure 25. Global Rivaroxaban Sales Market Share by Region (2017-2022)
Figure 26. Global Rivaroxaban Revenue Market Share by Country/Region in 2021
Figure 27. Americas Rivaroxaban Sales 2017-2022 (M Units)
Figure 28. Americas Rivaroxaban Revenue 2017-2022 ($ Millions)
Figure 29. APAC Rivaroxaban Sales 2017-2022 (M Units)
Figure 30. APAC Rivaroxaban Revenue 2017-2022 ($ Millions)
Figure 31. Europe Rivaroxaban Sales 2017-2022 (M Units)
Figure 32. Europe Rivaroxaban Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Rivaroxaban Sales 2017-2022 (M Units)
Figure 34. Middle East & Africa Rivaroxaban Revenue 2017-2022 ($ Millions)
Figure 35. Americas Rivaroxaban Sales Market Share by Country in 2021
Figure 36. Americas Rivaroxaban Revenue Market Share by Country in 2021
Figure 37. United States Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Rivaroxaban Sales Market Share by Region in 2021
Figure 42. APAC Rivaroxaban Revenue Market Share by Regions in 2021
Figure 43. China Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Rivaroxaban Sales Market Share by Country in 2021
Figure 50. Europe Rivaroxaban Revenue Market Share by Country in 2021
Figure 51. Germany Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Rivaroxaban Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Rivaroxaban Revenue Market Share by Country in 2021
Figure 58. Egypt Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Rivaroxaban in 2021
Figure 64. Manufacturing Process Analysis of Rivaroxaban
Figure 65. Industry Chain Structure of Rivaroxaban
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
